Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025On track to initiate U.S.

Do we really have to go through all of this again? This question is on the minds of millions of Floridians as hurricane ...

近日，备受全球华人瞩目的2024年福布斯全球华人精英TOP 100榜单正式揭晓，康蒂尼药业董事会主席罗楹凭借其*的领导力和在医药创新领域的杰出贡献成功入选。这份荣誉不仅彰显了罗楹个人的*成就与不懈努力，更凸显了康蒂尼药业在医药行业的*地位和深远影响。

Easter Island, also known as Rapa Nui by the locals, is a remote island off the coast of Chile. As of 2023, its population ...

SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic ...

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated ...

A system in Caribbean has a high chance for development between Oct. 31 and Nov. 4, according to AccuWeather. Will it become ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In trading on Friday, shares of Gyre Therapeutics Inc (Symbol: GYRE) crossed above their 200 day moving average of $14.43, changing hands as high as $14.83 per share. Gyre Therapeutics Inc shares ...

Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA, with a primary focus on the development and commercialization of F351 (Hydronidone) for the treatment of MASH ...